<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Biochemistry of Alzheimer's disease,Acetylcholine,Acetylcholinesterase,Alpha helix,Alzheimer's disease,Amyloid,Amyloid beta,Amyloid precursor protein,Apoptosis,Atrophy,Axon" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Biochemistry of Alzheimer's disease - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Biochemistry of Alzheimer's disease</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    	    <!-- start content -->
	    <p><a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Alzheimer's disease">Alzheimer's disease</a> (AD), one of the most common causes of adult <a href="../../../d/e/m/Dementia.html" title="Dementia">dementia</a>, is as yet not well understood at the molecular level. It has been identified as a <a href="../../../p/r/o/Protein_folding.html" title="Protein folding">protein misfolding</a> disease due to the accumulation of abnormally folded <a href="../../../a/m/y/Amyloid_beta.html" title="Amyloid beta">amyloid beta</a> protein in the brains of AD patients.<sup id="_ref-Hashimoto_0" class="reference"><a href="#_note-Hashimoto" title="">[1]</a></sup> Amyloid beta, also written AÎ², is a short <a href="../../../p/e/p/Peptide.html" title="Peptide">peptide</a> that is an abnormal <a href="../../../p/r/o/Proteolysis.html" title="Proteolysis">proteolytic</a> byproduct of the <a href="../../../t/r/a/Transmembrane_protein.html" title="Transmembrane protein">transmembrane protein</a> <a href="../../../a/m/y/Amyloid_precursor_protein.html" title="Amyloid precursor protein">amyloid precursor protein</a> (APP), whose function is unclear but thought to be involved in neuronal development.<sup id="_ref-Kerr_0" class="reference"><a href="#_note-Kerr" title="">[2]</a></sup> The <a href="../../../p/r/e/Presenilin.html" title="Presenilin">presenilins</a> are components of proteolytic complex involved in APP processing and degradation.<sup id="_ref-Cai_0" class="reference"><a href="#_note-Cai" title="">[3]</a></sup></p>
<p>Amyloid beta <a href="../../../m/o/n/Monomer.html" title="Monomer">monomers</a> are soluble and contain short regions of <a href="../../../b/e/t/Beta_sheet.html" title="Beta sheet">beta sheet</a> and <a href="../../../p/o/l/Polyproline_helix.html" title="Polyproline helix">polyproline II helix</a> <a href="../../../s/e/c/Secondary_structure.html" title="Secondary structure">secondary structures</a> in solution,<sup id="_ref-Danielsson_0" class="reference"><a href="#_note-Danielsson" title="">[4]</a></sup> though they are largely <a href="../../../a/l/p/Alpha_helix.html" title="Alpha helix">alpha helical</a> in membranes;<sup id="_ref-Tomaselli_0" class="reference"><a href="#_note-Tomaselli" title="">[5]</a></sup> however, at sufficiently high concentration, they undergo a dramatic <a href="../../../c/o/n/Conformational_change.html" title="Conformational change">conformational change</a> to form a <a href="../../../b/e/t/Beta_sheet.html" title="Beta sheet">beta sheet</a>-rich <a href="../../../t/e/r/Tertiary_structure.html" title="Tertiary structure">tertiary structure</a> that aggregates to form <a href="../../../a/m/y/Amyloid.html" title="Amyloid">amyloid fibrils</a>.<sup id="_ref-Ohnishi_0" class="reference"><a href="#_note-Ohnishi" title="">[6]</a></sup> These fibrils deposit outside neurons in dense formations known as <i>senile plaques</i> or <i>neuritic plaques</i>, in less dense aggregates as <i>diffuse plaques</i>, and sometimes in the walls of small blood vessels in the brain in a process called amyloid angiopathy or <a href="../../../c/o/n/Congophilic_angiopathy.html" title="Congophilic angiopathy">congophilic angiopathy</a>.</p>
<p>AD is also considered a <a href="../../../t/a/u/Tauopathy.html" title="Tauopathy">tauopathy</a> due to abnormal aggregation of the <a href="../../../t/a/u/Tau_protein.html" title="Tau protein">tau protein</a>, a <a href="../../../m/i/c/Microtubule-associated_protein.html" title="Microtubule-associated protein">microtubule-associated protein</a> expressed in neurons that normally acts to stabilize <a href="../../../m/i/c/Microtubules.html" title="Microtubules">microtubules</a> in the cell <a href="../../../c/y/t/Cytoskeleton.html" title="Cytoskeleton">cytoskeleton</a>. Like most microtubule-associated proteins, tau is normally regulated by <a href="../../../p/h/o/Phosphorylation.html" title="Phosphorylation">phosphorylation</a>; however, in AD patients, hyperphosphorylated tau accumulates as paired helical filaments<sup id="_ref-Goedert_0" class="reference"><a href="#_note-Goedert" title="">[7]</a></sup> that in turn aggregate into masses inside nerve cell bodies known as <i>neurofibrillary tangles</i> and as dystrophic <a href="../../../n/e/u/Neurite.html" title="Neurite">neurites</a> associated with amyloid plaques. Although little is known about the process of filament assembly, it has recently been shown that a depletion of a <a href="../../../p/r/o/Prolyl_isomerase.html" title="Prolyl isomerase">prolyl isomerase</a> protein in the <a href="../../../p/a/r/Parvulin.html" title="Parvulin">parvulin</a> family accelerates the accumulation of abnormal tau. <sup id="_ref-Pastorino_0" class="reference"><a href="#_note-Pastorino" title="">[8]</a></sup><sup id="_ref-Lim_0" class="reference"><a href="#_note-Lim" title="">[9]</a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Neuropathology"><span class="tocnumber">1</span> <span class="toctext">Neuropathology</span></a></li>
<li class="toclevel-1"><a href="#Disease_mechanism"><span class="tocnumber">2</span> <span class="toctext">Disease mechanism</span></a>
<ul>
<li class="toclevel-2"><a href="#Cholinergic_hypothesis"><span class="tocnumber">2.1</span> <span class="toctext">Cholinergic hypothesis</span></a></li>
<li class="toclevel-2"><a href="#Tau_hypothesis"><span class="tocnumber">2.2</span> <span class="toctext">Tau hypothesis</span></a></li>
<li class="toclevel-2"><a href="#Amyloid_hypothesis"><span class="tocnumber">2.3</span> <span class="toctext">Amyloid hypothesis</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">3</span> <span class="toctext">References</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Neuropathology" id="Neuropathology"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biochemistry_of_Alzheimer%27s_disease_9146.html" title="Edit section: Neuropathology">edit</a>]</span> <span class="mw-headline">Neuropathology</span></h2>
<p>Both amyloid plaques and neurofibrillary tangles are clearly visible by <a href="../../../m/i/c/Microscopy.html" title="Microscopy">microscopy</a> in AD brains.<sup id="_ref-Tiraboschi_0" class="reference"><a href="#_note-Tiraboschi" title="">[10]</a></sup> At an anatomical level, AD is characterized by gross diffuse atrophy of the brain and loss of neurons, neuronal processes and synapses in the <a href="../../../c/e/r/Cerebral_cortex.html" title="Cerebral cortex">cerebral cortex</a> and certain subcortical regions. This results in gross <a href="../../../a/t/r/Atrophy.html" title="Atrophy">atrophy</a> of the affected regions, including degeneration in the <a href="../../../t/e/m/Temporal_lobe.html" title="Temporal lobe">temporal lobe</a> and <a href="../../../p/a/r/Parietal_lobe.html" title="Parietal lobe">parietal lobe</a>, and parts of the <a href="../../../f/r/o/Frontal_cortex.html" title="Frontal cortex">frontal cortex</a> and <a href="../../../c/i/n/Cingulate_gyrus.html" title="Cingulate gyrus">cingulate gyrus</a>.<sup id="_ref-Wenk_0" class="reference"><a href="#_note-Wenk" title="">[11]</a></sup> Levels of the neurotransmitter <a href="../../../a/c/e/Acetylcholine.html" title="Acetylcholine">acetylcholine</a> are reduced. Levels of the neurotransmitters <a href="../../../s/e/r/Serotonin.html" title="Serotonin">serotonin</a>, <a href="../../../n/o/r/Norepinephrine.html" title="Norepinephrine">norepinephrine</a>, and <a href="../../../s/o/m/Somatostatin.html" title="Somatostatin">somatostatin</a> are also often reduced. <a href="../../../g/l/u/Glutamate.html" title="Glutamate">Glutamate</a> levels are usually elevated.<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></p>
<p><a name="Disease_mechanism" id="Disease_mechanism"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biochemistry_of_Alzheimer%27s_disease_9146.html" title="Edit section: Disease mechanism">edit</a>]</span> <span class="mw-headline">Disease mechanism</span></h2>
<p>Although the gross histological features of AD in the brain are well characterized, three major hypotheses have been advanced regarding the primary cause. The oldest hypothesis suggests that deficiency in <a href="../../../c/h/o/Cholinergic.html" title="Cholinergic">cholinergic</a> signaling initiates the progression of the disease. Two alternative misfolding hypotheses instead suggest that either tau protein or amyloid beta initiates the cascade. While researchers have not identified a clear causative pathway originating from any of the three molecular hypotheses to explain the gross anatomical changes observed in advanced AD, variants of the amyloid beta hypothesis of molecular initiation have become dominant among the three possibilities.</p>
<p><a name="Cholinergic_hypothesis" id="Cholinergic_hypothesis"></a></p>
<h3><span class="editsection">[<a href="../../../b/i/o/Biochemistry_of_Alzheimer%27s_disease_9146.html" title="Edit section: Cholinergic hypothesis">edit</a>]</span> <span class="mw-headline">Cholinergic hypothesis</span></h3>
<p>The oldest hypothesis is the "cholinergic hypothesis". It states that Alzheimer's begins as a deficiency in the production of <a href="../../../a/c/e/Acetylcholine.html" title="Acetylcholine">acetylcholine</a>, a vital <a href="../../../n/e/u/Neurotransmitter.html" title="Neurotransmitter">neurotransmitter</a>. Much early therapeutic research was based on this hypothesis, including restoration of the "cholinergic nuclei". The possibility of cell-replacement therapy was investigated on the basis of this hypothesis. All of the first-generation anti-Alzheimer's medications are based on this hypothesis and work to preserve acetylcholine by inhibiting <a href="../../../a/c/e/Acetylcholinesterase.html" title="Acetylcholinesterase">acetylcholinesterases</a> (enzymes that break down acetylcholine). These medications, though sometimes beneficial, have not led to a cure. In all cases, they have served to only treat symptoms of the disease and have neither halted nor reversed it. These results and other research have led to the conclusion that acetylcholine deficiencies may not be directly causal, but are a result of widespread brain tissue damage, damage so widespread that cell-replacement therapies are likely to be impractical. More recently, cholinergic effects have been proposed as a potential causative agent for the formation of plaques and tangles<sup id="_ref-Shen_0" class="reference"><a href="#_note-Shen" title="">[12]</a></sup> leading to generalized neuroinflammation.<sup id="_ref-Wenk_1" class="reference"><a href="#_note-Wenk" title="">[11]</a></sup></p>
<p>More recent hypotheses center on the effects of the misfolded and aggregated proteins, amyloid beta and tau. The two positions are lightheartedly described as "ba-ptist" and "tau-ist" viewpoints in scientific publications by Alzheimer's disease researchers. "Tau-ists" believe that the <a href="../../../t/a/u/Tau_protein.html" title="Tau protein">tau protein</a> abnormalities initiate the disease cascade, while "ba-ptists" believe that <a href="../../../b/e/t/Beta_amyloid.html" title="Beta amyloid">beta amyloid</a> deposits are the causative factor in the disease.<sup id="_ref-Mudher_0" class="reference"><a href="#_note-Mudher" title="">[13]</a></sup></p>
<p><a name="Tau_hypothesis" id="Tau_hypothesis"></a></p>
<h3><span class="editsection">[<a href="../../../b/i/o/Biochemistry_of_Alzheimer%27s_disease_9146.html" title="Edit section: Tau hypothesis">edit</a>]</span> <span class="mw-headline">Tau hypothesis</span></h3>
<p>The hypothesis that tau is the primary causative factor has long been grounded in the observation that deposition of amyloid plaques does not correlate well with neuron loss.<sup id="_ref-Schmitz_0" class="reference"><a href="#_note-Schmitz" title="">[14]</a></sup> A mechanism for neurotoxicity has been proposed based on the loss of microtubule-stabilizing tau protein that leads to the degradation of the cytoskeleton.<sup id="_ref-Gray_0" class="reference"><a href="#_note-Gray" title="">[15]</a></sup> However, consensus has not been reached on whether tau hyperphosphorylation precedes or is caused by the formation of the abnormal helical filament aggregates.<sup id="_ref-Mudher_1" class="reference"><a href="#_note-Mudher" title="">[13]</a></sup> Support for the tau hypothesis also derives from the existence of other diseases known as <a href="../../../t/a/u/Tauopathy.html" title="Tauopathy">tauopathies</a> in which the same protein is identifiably misfolded.<sup id="_ref-Williams_0" class="reference"><a href="#_note-Williams" title="">[16]</a></sup> However, a majority of researchers support the alternative hypothesis that amyloid is the primary causative agent.<sup id="_ref-Mudher_2" class="reference"><a href="#_note-Mudher" title="">[13]</a></sup></p>
<p><a name="Amyloid_hypothesis" id="Amyloid_hypothesis"></a></p>
<h3><span class="editsection">[<a href="../../../b/i/o/Biochemistry_of_Alzheimer%27s_disease_9146.html" title="Edit section: Amyloid hypothesis">edit</a>]</span> <span class="mw-headline">Amyloid hypothesis</span></h3>
<p>The amyloid hypothesis is initially compelling because the gene for the amyloid beta precursor APP is located on <a href="../../../c/h/r/Chromosome_21.html" title="Chromosome 21">chromosome 21</a>, and patients with <a href="../../../t/r/i/Trisomy_21.html" title="Trisomy 21">trisomy 21</a> - better known as Down syndrome - who thus have an extra <a href="../../../g/e/n/Gene_dosage.html" title="Gene dosage">gene copy</a> almost universally exhibit AD-like disorders by 40 years of age.<sup id="_ref-Nistor_0" class="reference"><a href="#_note-Nistor" title="">[17]</a></sup><sup id="_ref-Lott_0" class="reference"><a href="#_note-Lott" title="">[18]</a></sup> The traditional formulation of the amyloid hypothesis points to the cytotoxicity of mature aggregated amyloid fibrils, which are believed to be the toxic form of the protein responsible for disrupting the cell's calcium ion homeostasis and thus inducing <a href="../../../a/p/o/Apoptosis.html" title="Apoptosis">apoptosis</a>.<sup id="_ref-Yankner_0" class="reference"><a href="#_note-Yankner" title="">[19]</a></sup> This hypothesis is supported by the observation that higher levels of a variant of the beta amyloid protein known to form fibrils faster <i>in vitro</i> correlate with earlier onset and greater cognitive impairment in mouse models.<sup id="_ref-Iijima_0" class="reference"><a href="#_note-Iijima" title="">[20]</a></sup> and with AD diagnosis in humans.<sup id="_ref-Gregory_0" class="reference"><a href="#_note-Gregory" title="">[21]</a></sup> However, mechanisms for the induced calcium influx, or proposals for alternative cytotoxic mechanisms, by mature fibrils are not obvious.</p>
<p>A more recent and broadly supported variation of the amyloid hypothesis identifies the cytotoxic species as an intermediate misfolded form of amyloid beta, neither a soluble monomer nor a mature aggregated polymer but an <a href="../../../o/l/i/Oligomer.html" title="Oligomer">oligomeric</a> species, possibly toroidal or star-shaped with a central channel<sup id="_ref-Blanchard1_0" class="reference"><a href="#_note-Blanchard1" title="">[22]</a></sup> that may induce apoptosis by physically piercing the cell membrane.<sup id="_ref-Abramov_0" class="reference"><a href="#_note-Abramov" title="">[23]</a></sup> A related alternative suggests that a globular oligomer localized to <a href="../../../d/e/n/Dendrite.html" title="Dendrite">dendritic processes</a> and <a href="../../../a/x/o/Axon.html" title="Axon">axons</a> in neurons is the cytotoxic species.<sup id="_ref-Barghorn_0" class="reference"><a href="#_note-Barghorn" title="">[24]</a></sup><sup id="_ref-Kokubo_0" class="reference"><a href="#_note-Kokubo" title="">[25]</a></sup></p>
<p>Relevantly, the cytotoxic-fibril hypothesis presented a clear target for drug development: inhibit the fibrillization process. Much early development work on lead compounds has focused on this inhibition<sup id="_ref-Blanchard2_0" class="reference"><a href="#_note-Blanchard2" title="">[26]</a></sup><sup id="_ref-Porat_0" class="reference"><a href="#_note-Porat" title="">[27]</a></sup><sup id="_ref-Kanapathipillai_0" class="reference"><a href="#_note-Kanapathipillai" title="">[28]</a></sup>; most are also reported to reduce neurotoxicity, but the toxic-oligomer theory would imply that prevention of oligomeric assembly is the more important process<sup id="_ref-Lee_0" class="reference"><a href="#_note-Lee" title="">[29]</a></sup> or that a better target lies upstream, for example in the inhibition of APP processing to amyloid beta.<sup id="_ref-Espeseth_0" class="reference"><a href="#_note-Espeseth" title="">[30]</a></sup></p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biochemistry_of_Alzheimer%27s_disease_9146.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small">
<ol class="references">
<li id="_note-Hashimoto"><b><a href="#_ref-Hashimoto_0" title="">^</a></b> Hashimoto M, Rockenstein E, Crews L, Masliah E. (2003). Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases. <i>Neuromolecular Med</i> 4(1-2):21-36.</li>
<li id="_note-Kerr"><b><a href="#_ref-Kerr_0" title="">^</a></b> Kerr ML, Small DH. (2005). Cytoplasmic domain of the Î²-amyloid protein precursor of Alzheimer's disease: Function, regulation of proteolysis, and implications for drug development. <i>J Neurosci Res</i> 80(2):151-9.</li>
<li id="_note-Cai"><b><a href="#_ref-Cai_0" title="">^</a></b> Cai D, Netzer WJ, Zhong M, Lin Y, Du G, Frohman M, Foster DA, Sisodia SS, Xu H, Gorelick FS, Greengard P. (2006). Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation. <i>Proc Natl Acad Sci USA</i> 103(6):1941-6.</li>
<li id="_note-Danielsson"><b><a href="#_ref-Danielsson_0" title="">^</a></b> Danielsson J, Andersson A, Jarvet J, Graslund A. (2006). 15N relaxation study of the amyloid beta-peptide: structural propensities and persistence length. <i>Magn Reson Chem</i> Spec No:S114-21.</li>
<li id="_note-Tomaselli"><b><a href="#_ref-Tomaselli_0" title="">^</a></b> Tomaselli, S., Esposito, V., Vangone, P., van Nuland, N.A., Bonvin, A.M., Guerrini, R., Tancredi, T., Temussi, P.A., Picone, D. (2006). The alpha-to-beta Conformational Transition of Alzheimer's Abeta-(1-42) Peptide in Aqueous Media is Reversible: A Step by Step Conformational Analysis Suggests the Location of beta Conformation Seeding. <i>Chembiochem</i> 7:257-67</li>
<li id="_note-Ohnishi"><b><a href="#_ref-Ohnishi_0" title="">^</a></b> Ohnishi S, Takano K. (2004). Amyloid fibrils from the viewpoint of protein folding. <i>Cell Mol Life Sci</i> 61(5):511-24.</li>
<li id="_note-Goedert"><b><a href="#_ref-Goedert_0" title="">^</a></b> Goedert M, Klug A, Crowther RA. (2006). Tau protein, the paired helical filament and Alzheimer's disease. <i>J Alzheimers Dis</i> 9(3S):195-207.</li>
<li id="_note-Pastorino"><b><a href="#_ref-Pastorino_0" title="">^</a></b> Pastorino L, Shyun A, Lu PJ, Zhou XZ, Balastik M, Finn G, Wulf G, Lim J, Li SH, Li X, Xia W, Nicholson LK, Lu KP. (2006). The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. <i>Nature</i> 440(7083):528-34.</li>
<li id="_note-Lim"><b><a href="#_ref-Lim_0" title="">^</a></b> Lim J, Lu KP. (2005). Pinning down phosphorylated tau and tauopathies. <i>Biochim Biophys Acta</i> 1739(2-3):311-22.</li>
<li id="_note-Tiraboschi"><b><a href="#_ref-Tiraboschi_0" title="">^</a></b> Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J. (2004). The importance of neuritic plaques and tangles to the development and evolution of AD. <i>Neurology</i> 62(11):1984-9.</li>
<li id="_note-Wenk">^ <a href="#_ref-Wenk_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Wenk_1" title=""><sup><i><b>b</b></i></sup></a> Wenk GL. (2003). Neuropathologic changes in Alzheimer's disease. <i>J Clin Psychiatry</i> 64 Suppl 9:7-10.</li>
<li id="_note-Shen"><b><a href="#_ref-Shen_0" title="">^</a></b> Shen ZX. (2004). Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease. <i>Med Hypotheses</i> 63(2):308-21.</li>
<li id="_note-Mudher">^ <a href="#_ref-Mudher_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Mudher_1" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-Mudher_2" title=""><sup><i><b>c</b></i></sup></a> Mudher A, Lovestone S. (2002). Alzheimer's disease-do tauists and baptists finally shake hands? <i>Trends Neurosci</i> 25(1):22-6.</li>
<li id="_note-Schmitz"><b><a href="#_ref-Schmitz_0" title="">^</a></b> Schmitz C, Rutten BP, Pielen A, Schafer S, Wirths O, Tremp G, Czech C, Blanchard V, Multhaup G, Rezaie P, Korr H, Steinbusch HW, Pradier L, Bayer TA. (2004). Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. <i>Am J Pathol</i> 164(4):1495-502.</li>
<li id="_note-Gray"><b><a href="#_ref-Gray_0" title="">^</a></b> Gray EG, Paula-Barbosa M, Roher A. (1987). Alzheimer's disease: paired helical filaments and cytomembranes. <i>Neuropathol Appl Neurobiol</i> 13(2):91-110.</li>
<li id="_note-Williams"><b><a href="#_ref-Williams_0" title="">^</a></b> Williams DR. (2006). Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. <i>Intern Med J</i> 36(10):652-60.</li>
<li id="_note-Nistor"><b><a href="#_ref-Nistor_0" title="">^</a></b> Nistor M, Don M, Parekh M, Sarsoza F, Goodus M, Lopez GE, Kawas C, Leverenz J, Doran E, Lott IT, Hill M, Head E. (2006). Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain. <i>Neurobiol Aging</i> Epub.</li>
<li id="_note-Lott"><b><a href="#_ref-Lott_0" title="">^</a></b> Lott IT, Head E. (2005). Alzheimer disease and Down syndrome: factors in pathogenesis. <i>Neurobiol Aging</i> 26(3):383-9.</li>
<li id="_note-Yankner"><b><a href="#_ref-Yankner_0" title="">^</a></b> Yankner BA, Duffy LK, Kirschner DA. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides <i>Science</i> 250(4978): 279-282.</li>
<li id="_note-Iijima"><b><a href="#_ref-Iijima_0" title="">^</a></b> Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y. (2004). Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. <i>Proc Natl Acad Sci USA</i> 101(17):6623-8.</li>
<li id="_note-Gregory"><b><a href="#_ref-Gregory_0" title="">^</a></b> Gregory GC, Halliday GM. (2005). What is the dominant Abeta species in human brain tissue? A review. <i>Neurotox Res</i> 7(1-2):29-41.</li>
<li id="_note-Blanchard1"><b><a href="#_ref-Blanchard1_0" title="">^</a></b> Blanchard BJ, Hiniker AE, Lu CC, Margolin Y, Yu AS, Ingram VM. (2000). Elimination of Amyloid beta neurotoxicity. <i>J Alzheimers Dis</i> 2(2):137-149.</li>
<li id="_note-Abramov"><b><a href="#_ref-Abramov_0" title="">^</a></b> Abramov AY, Canevari L, Duchen MR. (2004). Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture. <i>Biochim Biophys Acta</i> 1742(1-3):81-7.</li>
<li id="_note-Barghorn"><b><a href="#_ref-Barghorn_0" title="">^</a></b> Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, Janson B, Bahr M, Schmidt M, Bitner RS, Harlan J, Barlow E, Ebert U, Hillen H. (2005). Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. <i>J Neurochem</i> 95(3):834-47.</li>
<li id="_note-Kokubo"><b><a href="#_ref-Kokubo_0" title="">^</a></b> Kokubo H, Kayed R, Glabe CG, Yamaguchi H. (2005). Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. <i>Brain Res</i> 1031(2):222-8.</li>
<li id="_note-Blanchard2"><b><a href="#_ref-Blanchard2_0" title="">^</a></b> Blanchard BJ, Chen A, Rozeboom LM, Stafford KA, Weigele P, Ingram VM. (2004). Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. <i>Proc Natl Acad Sci USA</i> 101(40):14326-14332.</li>
<li id="_note-Porat"><b><a href="#_ref-Porat_0" title="">^</a></b> Porat Y, Abramowitz A, Gazit E. (2006). Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. <i>Chem Biol Drug Des</i> 67(1):27-37.</li>
<li id="_note-Kanapathipillai"><b><a href="#_ref-Kanapathipillai_0" title="">^</a></b> Kanapathipillai M, Lentzen G, Sierks M, Park CB. (2005). Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid. <i>FEBS Lett</i> 579(21):4775-80.</li>
<li id="_note-Lee"><b><a href="#_ref-Lee_0" title="">^</a></b> Lee KH, Shin BH, Shin KJ, Kim DJ, Yu J. (2005). A hybrid molecule that prohibits amyloid fibrils and alleviates neuronal toxicity induced by beta-amyloid (1-42). <i>Biochem Biophys Res Commun</i> 328(4):816-23.</li>
<li id="_note-Espeseth"><b><a href="#_ref-Espeseth_0" title="">^</a></b> Espeseth AS, Xu M, Huang Q, Coburn CA, Jones KL, Ferrer M, Zuck PD, Strulovici B, Price EA, Wu G, Wolfe AL, Lineberger JE, Sardana M, Tugusheva K, Pietrak BL, Crouthamel MC, Lai MT, Dodson EC, Bazzo R, Shi XP, Simon AJ, Li Y, Hazuda DJ. (2005). Compounds that bind APP and inhibit Abeta processing in vitro suggest a novel approach to Alzheimer disease therapeutics. <i>J Biol Chem</i> 280(18):17792-7.</li>
</ol>
</div>

<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../b/i/o/Biochemistry_of_Alzheimer%27s_disease_9146.html">http://en.wikipedia.org../../../b/i/o/Biochemistry_of_Alzheimer%27s_disease_9146.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_with_unsourced_statements_since_February_2007_f7dc.html" title="Category:Articles with unsourced statements since February 2007">Articles with unsourced statements since February 2007</a></span> | <span dir='ltr'><a href="../../../a/l/l/Category%7EAll_articles_with_unsourced_statements_2f67.html" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="../../../a/l/z/Category%7EAlzheimer%27s_disease_c69a.html" title="Category:Alzheimer's disease">Alzheimer's disease</a></span> | <span dir='ltr'><a href="../../../n/e/u/Category%7ENeurology_7728.html" title="Category:Neurology">Neurology</a></span> | <span dir='ltr'><a href="../../../u/n/s/Category%7EUnsolved_problems_in_neuroscience_b233.html" title="Category:Unsolved problems in neuroscience">Unsolved problems in neuroscience</a></span> | <span dir='ltr'><a href="../../../p/a/t/Category%7EPathology_c83f.html" title="Category:Pathology">Pathology</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../b/i/o/Biochemistry_of_Alzheimer%27s_disease_9146.html">Article</a></li><li id="ca-talk"
	       class="new"	       ><a href="../../../b/i/o/Talk%7EBiochemistry_of_Alzheimer%27s_disease_06d3.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Biochemistry_of_Alzheimer%27s_disease">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 17:04, 1 March 2007 by Anonymous user(s) of Wikipedia. Based on work by Wikipedia user(s) <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a> and <a href="../../../o/p/a/User%7EOpabinia_regalis_4201.html" title="User:Opabinia regalis">Opabinia regalis</a>.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
